VANCOUVER, Dec. 10 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced today that in conjunction with its annual evaluation process it has issued a combined total of 150,000 incentive stock options to six directors of the Company exercisable at $1.38 for a period of five years pursuant to its Stock Option Plan. Its Stock Option Plan has been approved by Shareholders and the TSX Venture Exchange.
About CRH Medical Corporation:
CRH Medical Corporation is a value added resource to the Gastroenterologist community, providing the CRH O'Regan System, as well as delivering related, clinical, marketing and operational support directly to its partner physicians. CRH utilizes its web based platform to connect doctors with patients as well as educating its ever increasing install base of physicians. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. The Company's goal is to establish the CRH O'Regan System as the standard for hemorrhoid treatment.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this
For further information: For further information:
Dean Linden, Corporate Communications, CRH Medical Corporation at 604.633.1440 or email@example.com. Additional information may also be found by visiting the Company's website at www.crhmedcorp.com or the SEDAR website at www.sedar.com.